Rapid discovery of putative protein biomarkers of traumatic brain injury by SDS-PAGE-capillary liquid chromatography-tandem mass spectrometry

Journal of Neurotrauma

Volumn 22, Issue 6, 2005, Pages 629-644

  Haskins, William E ^a,b,c   Kobeissy, Firas H ^a,b,c   Wolper, Regina A ^a,b,c   Ottens, Andrew K ^a,b,c   Kitlen, Jason W ^b,c   McClung, Scott H ^d   O'Steen, Barbara E ^b,c   Chow, Marjorie M ^d   Pineda, Jose A ^b   Denslow, Nancy D ^a,d   Hayes, Ronald L ^b,c   Wang, Kevin K W ^a,b,c,d  

^a Center of Neuroproteomics and Biomarkers Research   (United States)

^b Center for Traumatic Brain Injury Studies   (United States)

^c Department of Psychiatry ^*  (United States)

^d UNIVERSITY OF FLORIDA   (United States)

Author keywords

Controlled cortical impact (CCI); Differential in gel electrophoresis (DIGE); Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS PAGE); Tandem mass spectometry (MS2); Traumatic brain injury (TBI)

Indexed keywords

BIOLOGICAL MARKER; CREATINE KINASE; CYANINE DYE; NEURON SPECIFIC ENOLASE; PROTEIN; SPECTRIN;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CAPILLARY LIQUID CHROMATOGRAPHY; CONTROLLED STUDY; DIFFERENTIAL IN GEL ELECTROPHORESIS; GEL ELECTROPHORESIS; HIPPOCAMPUS; IN VITRO STUDY; LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN DATABASE; PROTEIN DEGRADATION; PROTEOMICS; RAT; TANDEM MASS SPECTROMETRY; UNINDEXED SEQUENCE;

AMINO ACID SEQUENCE; ANIMALS; BIOLOGICAL MARKERS; BRAIN INJURIES; CHROMATOGRAPHY, LIQUID; CREATINE KINASE; DATABASES, PROTEIN; DISEASE MODELS, ANIMAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HIPPOCAMPUS; MALE; MASS SPECTROMETRY; NERVE TISSUE PROTEINS; NEUROCHEMISTRY; PHOSPHOPYRUVATE HYDRATASE; PREDICTIVE VALUE OF TESTS; PROTEOMICS; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; SPECTRIN; TIME FACTORS; UP-REGULATION;

EID: 20544442753     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2005.22.629     Document Type: Article

References (41)

1. 2+-activated neutral proteinase associated with purified myelin of rat CNS. J Neurochem. 45, 581-588.
2. BERGER, R.P., PIERCE, M.C., WISNIEWSKI, S.R., et al. (2002). Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children. Pediatrics 109, E31.
3. BODOVITZ, S., and JOOS, T. (2004). The proteomics bottle-neck: strategies for preliminary validation of potential biomarkers and drug targets. Trends Biotechnol. 22, 4-7.
4. BRAMLETT, H.M. and DIETRICH, W.D. (2003). Synuclein aggregation: possible role in traumatic brain injury. Exp. Neurol. 184, 27-30.
5. BUKI, A., OKONKWO, D.O., WANG, K.K.W., and POVLISHOCK, J.T. (2000). Cytochrome c release and caspase activation in traumatic axonal injury. J. Neurosci. 20, 2825-2834.
6. DENSLOW, N., MICHEL, M.E., TEMPLE, M.D., HSU, C.Y., SAATMAN, K., and HAYES, R.L. (2003). Application of proteomics technology to the field of neurotrauma. J. Neurotrauma 20, 401-407.
7. DIXON, C.E., CLIFTON, G.L., LIGHTHALL, J.W., YAGHAMAI, A.A., and HAYES, R.L. (1991). A controlled cortical impact model of traumatic brain injury in the rat. J. Neurosci. Methods 39, 253-262.
8. DOMANSKA-JANIK, K., DE NECHAUD, B., INOMATA, M., KAWASHIMA, S., and ZALEWSKA, T. (1992). Calcium-activated neutral protease (CANP). in normal and dysmyelinating mutant paralytic tremor rabbit myelin. Mol. Chem. Neuropathol. 16, 273-288.
9. FOUNTOULAKIS, M., SCHULLER, E., HARDMEIER, R., BERNDT, P., and LUBEC, G. (1999a). Rat brain proteins: two-dimensional protein database and variations in the expression level. Electrophoresis 20, 3572-3579.
10. FOUNTOULAKIS, M., SCHULLER, E., HARDMEIER, R., BERNDT, P. and, LUBEC, G. (1999b). Rat brain proteins: two-dimensional protein database and variations in the expression level. Electrophoresis 20, 3572-3579.
11. FRANZ, G., BEER, R., KAMPFL, A., et al. (2003). Amyloid beta 1-42, and tau in cerebrospinal fluid after severe traumatic brain injury. Neurology 60, 1457-1461.
12. GERBER, S.A., RUSH, J., STEMMAN, O., KIRSCHNER, M.W., and GYGI, S.P. (2003). Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc. Natl. Acad. Sci. USA 100, 6940-6945.
13. GHARBI, S., GAFFNEY, P., YANG, A., et al. (2002). Evaluation of two-dimensional differential gel electrophoresis for proteomic expression analysis of a model breast cancer cell system. Mol. Cell. Proteomics 1, 91-98.
14. GYGI, S.P., RIST, B., GERBER, S.A., TURECEK, F., GELB, M.H., and AEBERSOLD, R. (1999). Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 17, 994-999.
15. 2 at the attomole level for monitoring and discovering endogenous peptides in microdialysis samples collected in vivo. Anal. Chem. 73, 5005-5014.
16. HUH, J.W., RAGHUPATHI, R., LAURER, H.L., HELFAER, M.A., and SAATMAN, K.E. (2003). Transient loss of microtubule-associated protein 2 immunoreactivity after moderate brain injury in mice. J. Neurotrauma 20, 975-984.
17. JENKINS, L.W., PETERS, G.W., DIXON, C.E., et al. (2002). Conventional and functional proteomics using large format two-dimensional gel electrophoresis 24 hours after controlled cortical impact in postnatal day 17 rats. J. Neurotrauma 19, 715-740.
18. KERNEC, F., UNLU, M., LABEIKOVSKY, W., MINDEN, J.S., and KORETSKY, A.P. (2001). Changes in the mitochondrial proteome from mouse hearts deficient in creatine kinase. Physiol. Genomics 6, 117-128.
19. KORNBLUM, H.I., and GESCHWIND, D.H. (2001). Molecular markers in CNS stem cell research: hitting a moving target. Nat. Rev. Neurosci. 2, 843-846.
20. LEIMGRUBER, R.M., MALONE, J.P., RADABAUGH, M.R., LAPORTE, M.L., VIOLAND, B.N., and MONAHAN, J.B. (2002). Development of improved cell lysis, solubilization and imaging approaches for proteomic analyses. Proteomics 2, 135-144.
21. MACDONALD, N., CHEVALIER, S., TONGE, R., et al. (2001). Quantitative proteomic analysis of mouse liver response to the peroxisome proliferator diethylhexylphthalate (DEHP). Arch. Toxicol. 75, 415-424.
22. MATZILEVICH, D.A., RALL, J.M., MOORE, A.N., GRILL, R.J., and DASH, P.K. (2002). High-density microarray analysis of hippocampal gene expression following experimental brain injury. J. Neurosci. Res. 67, 646-663.
23. MCDONALD, W.H., and YATES, J.R. (2002). Shotgun proteomics and biomarker discovery. Dis. Markers 18, 99-105.
24. NEWCOMB, J.K., KAMPFL, A., POSMANTUR, R.M., et al. (1997). Immunohistochemical study of calpain-mediated breakdown products to a-spectrin following controlled cortical impact injury in the rat. J. Neurotrauma 14, 369-383.
25. NEWELL, K.L., BOYER, P., GOMEZ-TORTOSA, E., et al. (1999). Alpha-synuclein immunoreactivity is present in axonal swellings in neuroaxonal dystrophy and acute traumatic brain injury. J. Neuropathol. Exp. Neurol. 58, 1263-1268.
26. PERKINS, D.N., PAPPIN, D.J., CREASY, D.M., and COTTRELL, J.S. (1999). Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20, 3551-3567.
27. PIKE, B.R., FLINT, J., DUTTA, S., WANG, D.S., WANG, K.K.W., and HAYES, R.L. (2002). Accumulation of spectrin and calpain-cleaved spectrin breakdown products in CSF after traumatic brain injury. J. Neurochem. 81, 73.
28. POSMANTUR, R.M., KAMPFL, A., LIU, S.I., et al. (1996). Cytoskeletal derangements of cortical neuronal processes three hours after traumatic brain injury in rats: an immunofluorescence study. J. Neuropathol. Exp. Neurol. 55, 68-80.
29. POSMANTUR, R., KAMPFL, A., SIMAN, R., et al. (1997). A calpain inhibitor attenuates cortical cytoskeletal protein loss after experimental traumatic brain injury in the rat. Neuroscience 77, 875-888.
30. POSMANTUR, R.M., ZHAO, X., KAMPFL, A., CLIFTON, G.L., and HAYES, R.L. (1998). Immunoblot analyses of the relative contributions of cysteine and aspartic proteases to neurofilament breakdown products following experimental brain injury in rats. Neurochem. Res. 10, 1265-1276.
31. PRUITT, K.D., and MAGLOTT, D.R. (2001). RefSeq and LocusLink: NCBI gene-centered resources. Nucleic Acids Res. 29, 137-140.
32. RAABE, A., KOPETSCH, O., WOSZCZYK, A., et al. (2003). Serum S-100B protein as a molecular marker in severe traumatic brain injury. Restor. Neurol. Neurosci. 21, 159-169.
33. SHAW, J., ROWLINSON, R., NICKSON, J., et al. (2003). Evaluation of saturation labeling two-dimensional difference gel electrophoresis fluorescent dyes. Proteomics 3, 1181-1195.
34. SMITH, D.H., URYU, K., SAATMAN, K.E., TROJANOWSKI, J.Q., and MCINTOSH, T.K. (2003). Protein accumulation in traumatic brain injury. Neuromol. Med. 4, 59-72.
35. TABB, D.L., MCDONALD, W.H., and YATES, J.R. (2002). DTASelect and contrast: tools for assembling and comparing protein identifications from shotgun proteomics. J. Proteome Res. 1, 21-26.
36. TONGE, R., SHAW, J., MIDDLETON, B., et al. (2001). Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology. Proteomics 1, 377-396.
37. URYU, K., GIASSON, B.I., LONGHI, L., et al. (2003). Age-dependent synuclein pathology following traumatic brain injury in mice. Exp. Neurol. 184, 214-224.
38. VARMA, S., JANESKO, K.L., WISNIEWSKI, S.R., et al. (2003). F-2-isoprostane and neuron-specific enolase in cerebrospinal fluid after severe traumatic brain injury in infants and children. J. Neurotrauma 20, 781-786.
39. YAN, J.X., DEVENISH, A.T., WAIT, R., STONE, T., LEWIS, S., and FOWLER, S. (2002). Fluorescence two-dimensional difference gel electrophoresis and mass spectrometry based proteomic analysis of Escherichia coli. Proteomics 2, 1682-1698.
40. YATES, J.R., MORGAN, S.F., GATLIN, C.L., GRIFFIN, P.R., and ENG, J.K. (1998). Method to compare collision-induced dissociation spectra of peptides: potential for library searching and subtractive analysis. Anal. Chem. 70, 3557-3565.
41. ZELMAN, F.P., JAUCH, E.G., MULCHAHEY, J.J., et al. (2002). C-tau biomarker of neuronal damage in severe brain-injured patients: association with elevated intracranial pressure and clinical outcome. Brain Res. 947, 131-139.